Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
Open Access
- 1 October 2011
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 19 (10), 1878-1886
- https://doi.org/10.1038/mt.2011.145
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decayNature, 2010
- Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancerNature Reviews Cancer, 2009
- Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti–neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant MiceCancer Research, 2008
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging AntibodyScience, 2008
- Development of targeted oncolytic virotherapeutics through translational researchExpert Opinion on Biological Therapy, 2008
- Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating AptamerCell Chemical Biology, 2008
- Cancer Immunotherapy UsingIn vitroGenetically Modified Targeted Dendritic CellsCancer Research, 2008
- CD137 Costimulation of CD8+ T Cells Confers Resistance to Suppression by Virus-Induced Regulatory T CellsThe Journal of Immunology, 2008
- OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejectionThe Journal of Experimental Medicine, 2008
- Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in miceJCI Insight, 2008